MedCap AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 456.6 million compared to SEK 322.8 million a year ago. Revenue was SEK 461.7 million compared to SEK 325.6 million a year ago.

Net income was SEK 62.2 million compared to SEK 40.3 million a year ago. Basic earnings per share from continuing operations was SEK 4.2 compared to SEK 2.7 a year ago. Diluted earnings per share from continuing operations was SEK 4.2 compared to SEK 2.7 a year ago.